EcoDrugPlus

60s Ribosomal Protein L21-Like

Ensembl ID : ENSPLOG00000018330
Gene Symbol: LOC122203930
3 Cross references
135 Possible Orthologues:

60s Ribosomal Protein L21-Like

Ensembl ID : ENSPLOG00000012180
Gene Symbol: LOC122226500
3 Cross references
135 Possible Orthologues:

60s Ribosomal Protein L21-Like

Ensembl ID : ENSPLOG00000021753
Gene Symbol: LOC122227038
3 Cross references
142 Possible Orthologues:

60s Ribosomal Protein L28-Like

Ensembl ID : ENSPLOG00000020585
Gene Symbol: LOC122205515
3 Cross references
191 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSPLOG00000011615
Gene Symbol: LOC122226902
3 Cross references
153 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSPLOG00000000083
Gene Symbol: LOC122226902
3 Cross references
158 Possible Orthologues:

60s Ribosomal Protein L30-Like

Ensembl ID : ENSPLOG00000007575
Gene Symbol: LOC122219057
3 Cross references
152 Possible Orthologues:

60s Ribosomal Protein L35a

Ensembl ID : ENSPLOG00000005859
Gene Symbol: LOC122200649
3 Cross references
128 Possible Orthologues:

60s Ribosomal Protein L39-Like

Ensembl ID : ENSPLOG00000020583
Gene Symbol: LOC122226338
3 Cross references
68 Possible Orthologues:

60s Ribosomal Protein L39-Like

Ensembl ID : ENSPLOG00000000716
Gene Symbol: LOC122216887
3 Cross references
68 Possible Orthologues:

60s Ribosomal Protein L39-Like

Ensembl ID : ENSPLOG00000012887
Gene Symbol: LOC122219157
3 Cross references
69 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPLOG00000022699
Gene Symbol: ARAF
2 Cross references
190 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).